CMAJ • April 10, 2007; 176 (8). doi:10.1503/cmaj.061288.
© 2007 Canadian Medical Association or its licensors
All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association.
This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brindley, P. G.
Right arrow Articles by Brindley, D. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brindley, P. G.
Right arrow Articles by Brindley, D. N.
Related Collections
Right arrow Alcohol
Right arrow Diagnostic tests
Right arrow Poisoning

Research

Case report

Falsely elevated point-of-care lactate measurement after ingestion of ethylene glycol

Peter G. Brindley, Matthew S. Butler, George Cembrowski and David N. Brindley

From the Divisions of Critical Care Medicine (P.G. Brindley) and Medical Biochemistry (Cembrowski), Departments of Surgery (Butler) and Biochemistry (D.N. Brindley), University of Alberta, Edmonton, Alta.

Background: A patient presented with severe acidosis and a point-of-care lactate measurement of 42 mmol/L. Mesenteric ischemia was suspected, with a potential need for laparotomy; however, plasma lactate measurements were below 4 mmol/L. Ethylene glycol ingestion was subsequently diagnosed. We therefore wished to determine why discrepancies in lactate measurements occur and whether this "lactate gap" could be clinically useful.

Methods: We phlebotomized blood, added various concentrations of metabolites of ethylene glycol, and tested the resulting samples with the 5 most common lactate analyzers.

Results: With the Radiometer 700 point-of-care analyzer, glycolate addition resulted in an artifactual, massive lactate elevation, even at low glycolate concentrations. Another major ethylene glycol metabolite, glyoxylate (but not oxalate or formate), caused similar elevations. The i-STAT and Bayer point-of-care analyzers and the Beckman and Vitros laboratory analyzers reported minimal lactate elevations. Lactate gap was determined by comparing the Radiometer result with the corresponding result from any of the other analyzers.

Interpretation: We demonstrated how inappropriate laparotomy or delayed therapy might occur if clinicians are unaware of this phenomenon or have access to only a single analyzer. We also showed that lactate gap can be exploited to expedite treatment, diagnose late ethylene-glycol ingestion and terminate dialysis. By comparing lactate results from the iSTAT or Bayer devices with that from the Radiometer, ethylene-glycol ingestion can be diagnosed at the point of care. This can expedite diagnosis and treatment by hours, compared with waiting for laboratory results for plasma ethylene glycol.




This article has been cited by other articles:


Home page
 CMAJHome page
P. G. Jorens MD PhD
Accuracy of point-of-care measurements
Can. Med. Assoc. J., October 23, 2007; 177(9): 1070 - 1070.
[Full Text] [PDF]

eLetters:

Read all eLetters

Point-of-care measurements and poisoning
Philippe G Jorens
CMAJ, 14 Aug 2007 [Full text]
Glycolate interference on Radiometer ABL analyser is influenced by age of lactate electrode
Weldon W Chiu
CMAJ, 30 Oct 2007 [Full text]